Skip to main content

Long-term Survivorship Care after Treatment for Cancer: A Workshop

Completed

The Institute of Medicine report, Lost in Transition, made recommendations to improve the quality of care for cancer survivors – a population at risk for an array of significant physical, psychosocial, and financial effects of cancer and cancer treatment. Since then, coordinated efforts to address the unique needs of cancer survivors have increased, including work to improve the evidence base for cancer survivorship care and to identify best practices in the delivery of high-quality cancer survivorship care. This workshop examined progress from 2006 to 2017 and considered potential actions to improve the planning, management, and delivery of cancer survivorship care.

Description

An ad hoc committee will plan and host a 1.5-day public workshop to examine the evidence for potential actions to improve the planning, management, and delivery of cancer survivorship care. The workshop will feature invited presentations and panel discussions on topics that may include:
• An overview of the health risks and late effects experienced by cancer survivors.
• The current evidence base to improve the quality of life for cancer survivors, including the identification, prevention, and reduction of long-term toxicities and second malignancies associated with prior cancer treatment.
• Strategies for early integration of psychosocial support in survivorship care.
• Opportunities to overcome challenges in accessing health care and minimizing the financial burden for cancer survivors.
• Implementation models and emerging strategies for coordinated cancer survivorship care in primary and specialty care settings, including the use of survivorship care plans tailored to a patient’s diagnosis and life course.
• Changes in the landscape of cancer survivorship care over the past decade.
The committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.

Collaborators

Sponsors

Abbott Laboratories

American Association for Cancer Research

American College of Radiology

American Society of Clinical Oncology

American Society of Hematology

Association of American Cancer Institutes

Bristol Myers Squibb

Cancer Support Community

Centers for Disease Control and Prevention (CDC)

CEO Roundtable on Cancer

Flatiron Health

Helsinn Therapeutics (U.S.), Inc.

LiveSTRONG Foundation

Merck

National Cancer Institute

National Comprehensive Cancer Network

National Institutes of Health

Novartis Oncology

Oncology Nursing Society

Pfizer Inc.

Staff

Sharyl Nass

Lead

Erin Balogh

Lead

Laura Aiuppa

Lead

Cyndi Trang

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.